BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31041820)

  • 1. Infectivity of murine papillomavirus in the surgical byproducts of treated tail warts.
    Best SR; Esquivel D; Mellinger-Pilgrim R; Roden RBS; Pitman MJ
    Laryngoscope; 2020 Mar; 130(3):712-717. PubMed ID: 31041820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of acquiring human papillomavirus from the plume produced by the carbon dioxide laser in the treatment of warts.
    Gloster HM; Roenigk RK
    J Am Acad Dermatol; 1995 Mar; 32(3):436-41. PubMed ID: 7868712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the presence of HPV on KTP laser fibers following KTP laser treatment of papilloma.
    Dodhia S; Baxter PC; Ye F; Pitman MJ
    Laryngoscope; 2018 Apr; 128(4):926-928. PubMed ID: 29171656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious papillomavirus in the vapor of warts treated with carbon dioxide laser or electrocoagulation: detection and protection.
    Sawchuk WS; Weber PJ; Lowy DR; Dzubow LM
    J Am Acad Dermatol; 1989 Jul; 21(1):41-9. PubMed ID: 2545749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection.
    Jiang RT; Wang JW; Peng S; Huang TC; Wang C; Cannella F; Chang YN; Viscidi RP; Best SRA; Hung CF; Roden RBS
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28515303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of human papillomavirus DNA in the plume of erbium:YAG laser-treated warts.
    Hughes PS; Hughes AP
    J Am Acad Dermatol; 1998 Mar; 38(3):426-8. PubMed ID: 9520024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The full transcription map of mouse papillomavirus type 1 (MmuPV1) in mouse wart tissues.
    Xue XY; Majerciak V; Uberoi A; Kim BH; Gotte D; Chen X; Cam M; Lambert PF; Zheng ZM
    PLoS Pathog; 2017 Nov; 13(11):e1006715. PubMed ID: 29176795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel In Vivo Model of Laryngeal Papillomavirus-Associated Disease Using
    King RE; Bilger A; Rademacher J; Ward-Shaw ET; Hu R; Lambert PF; Thibeault SL
    Viruses; 2022 May; 14(5):. PubMed ID: 35632742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airborne human papillomavirus (HPV) transmission risk during ablation procedures: A systematic review and meta-analysis.
    Palma S; Gnambs T; Crevenna R; Jordakieva G
    Environ Res; 2021 Jan; 192():110437. PubMed ID: 33181134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mus musculus Papillomavirus 1: a New Frontier in Animal Models of Papillomavirus Pathogenesis.
    Spurgeon ME; Lambert PF
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32051276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of genital human papillomavirus infection in a female adolescent population.
    Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
    Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of human papillomavirus type 124 in a viral wart located on a thigh.
    Sato S; Kan Y; Okura M; Sumikawa Y; Kato J; Kase K; Yamashita T
    J Dermatol; 2016 Sep; 43(9):1101-2. PubMed ID: 26992442
    [No Abstract]   [Full Text] [Related]  

  • 13. Mus musculus papillomavirus 1 is a key driver of skin cancer development upon immunosuppression.
    Dorfer S; Strasser K; Schröckenfuchs G; Bonelli M; Bauer W; Kittler H; Cataisson C; Fischer MB; Lichtenberger BM; Handisurya A
    Am J Transplant; 2021 Feb; 21(2):525-539. PubMed ID: 33063442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Larynx is Protected from Secondary and Vertical Papillomavirus Infection in Immunocompetent Mice.
    King RE; Rademacher J; Ward-Shaw ET; Hu R; Bilger A; Blaine-Sauer S; Spurgeon ME; Thibeault SL; Lambert PF
    Laryngoscope; 2024 May; 134(5):2322-2330. PubMed ID: 38084790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).
    Uberoi A; Yoshida S; Lambert PF
    J Virol Methods; 2018 Mar; 253():11-17. PubMed ID: 29253496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive human papillomavirus type 7-associated orofacial warts in an immunocompetent patient.
    Ritzkowsky A; Weissenborn S; Krieg T; Pfister H; Wieland U
    Acta Derm Venereol; 2001 May; 81(2):130-3. PubMed ID: 11501651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic characterization of a novel human papillomavirus (HPV-117) with a high viral load in a persisting wart.
    Köhler A; Gottschling M; Förster J; Röwert-Huber J; Stockfleth E; Nindl I
    Virology; 2010 Mar; 399(1):129-133. PubMed ID: 20096912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and typing of human papillomavirus in cutaneous warts of patients infected with human immunodeficiency virus type 1.
    Porro AM; Alchorne MM; Mota GR; Michalany N; Pignatari AC; Souza IE
    Br J Dermatol; 2003 Dec; 149(6):1192-9. PubMed ID: 14674896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel lineage-tracing mouse model for studying early MmuPV1 infections.
    Yilmaz V; Louca P; Potamiti L; Panayiotidis M; Strati K
    Elife; 2022 May; 11():. PubMed ID: 35533001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual transmission of murine papillomavirus (MmuPV1) in
    Spurgeon ME; Lambert PF
    Elife; 2019 Oct; 8():. PubMed ID: 31621578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.